Furthermore, our results revealed that RNF43 was significantly associated with the clinical stage in 4 cancer types, in which RNF43 expression levels were lower in later clinical stages, including KIRC, KIRP, THCA, and uveal melanoma (UVM) (Fig. 2D). Here, RNF43 is linked to uveal melanoma.